NewAmsterdam Pharma (NAMS) EBIT (2023 - 2026)
NewAmsterdam Pharma (NAMS) recorded EBIT of -$64.86 million in Q2 2026, compared with -$35.64 million a year earlier.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) EBIT (2023 - 2026) Analysis & Trends
On a TTM basis, NewAmsterdam Pharma's EBIT came in at -$244.41 million as of Jun 30, 2026; for FY2025, it was -$225.68 million.
- Across earlier years, EBIT came in at -$176.29 million in FY2024, -$182.97 million in FY2023, -$71.21 million in FY2022 and -$35.31 million in FY2021.
- Quarterly EBIT has ranged from -$68.93 million in Q1 2025 to -$25 million in Q3 2024 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$58.42 million (Q1 2026), -$65.98 million (Q4 2025) and -$55.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.27 Bn |
| 10 | NewAmsterdam Pharma | 2.66 Bn | 49.48 Mn | - | -64.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -64.86 Mn |
| Mar 31, 2026 | -58.42 Mn |
| Dec 31, 2025 | -65.98 Mn |
| Sep 30, 2025 | -55.14 Mn |
| Jun 30, 2025 | -35.64 Mn |
| Mar 31, 2025 | -68.93 Mn |
| Dec 31, 2024 | -43.23 Mn |
| Sep 30, 2024 | -25.00 Mn |
| Jun 30, 2024 | -52.58 Mn |
| Mar 31, 2024 | -55.48 Mn |
| Dec 31, 2023 | -51.07 Mn |
| Sep 30, 2023 | -49.56 Mn |
| Jun 30, 2023 | -42.48 Mn |
| Mar 31, 2023 | -39.85 Mn |
API Access
NewAmsterdam Pharma EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();